Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 16,892 | 18,827 | 13,306 | 13,146 | 3,021 |
| Cost of Goods | 2,274 | 1,884 | 1,010 | 824 | 128 |
| Gross Profit | 14,618 | 16,943 | 12,296 | 12,322 | 2,893 |
| Operating Expenses | 32,291 | 39,672 | 35,834 | 33,262 | 25,588 |
| Operating Income | -17,399 | -21,845 | -23,528 | -20,116 | -22,567 |
| Other Income | 52 | 410 | 475 | 615 | 505 |
| Pre-tax Income | -17,347 | -21,435 | -23,053 | -19,501 | -22,062 |
| Income Tax | -351 | -111 | N/A | -1,089 | N/A |
| Net Income Continuous | -16,996 | -21,324 | -23,053 | -18,412 | -22,062 |
| Net Income | $-16,996 | $-21,324 | $-23,053 | $-18,412 | $-22,062 |
| EPS Basic Total Ops | -0.81 | -1.01 | -1.15 | -1.07 | -1.29 |
| EPS Basic Continuous Ops | -0.81 | -1.01 | -1.15 | -1.06 | -1.29 |
| EPS Diluted Total Ops | -0.81 | -1.01 | -1.15 | -1.07 | -1.29 |
| EPS Diluted Continuous Ops | -0.81 | -1.01 | -1.15 | -1.06 | -1.29 |
| EBITDA(a) | $-16,146 | $-21,016 | $-22,925 | $-19,513 | $-22,007 |